Hortilano, Medie P.

HRN: 28-86-53  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2026
CO-AMOXICLAV 625MG (TAB)
06/25/2026
07/02/2026
PO
625mg
BID X 7 Days
UTI; S/P NSVD
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines